Find an expert

Dr María Patricia Hernández Mitre (Patty Mitre) is Postdoctoral Research Fellow in the Antimicrobial Optimisation Group led by Professor Jason Roberts and a member of the CRE-RESPOND (Centre of Research Excellence - REduce the burden of antimicrobial reSistance through oPtimal persONalised Dosing) team at the University of Queensland Centre for Clinical Research, located on the Royal Brisbane and Women's Hospital campus at Herston in Brisbane, Queensland, Australia.

She is certified in non-compartmental analysis (NCA) using Phoenix® WinNonlin™ and conducts NCA for Phase 1 clinical trials under NATA ISO 17025-accredited processes, preparing regulatory reports for submission to agencies such as the FDA. In addition, she develops and validates population pharmacokinetic models using Monolix®, Pmetrics™, and NONMEM® to optimise drug therapy and support therapeutic drug monitoring.

Dr Hernández Mitre is leading the individual pharmacokinetic analyses of antifungal therapies from the Screening Anti-Fungal Exposure in Intensive Care Units (SAFE-ICU) study. She also mentors students and clinicians, delivers training in pharmacokinetic modelling, and participates actively in university committees. She is experienced in clinical trial monitoring, regulatory writing, and electronic research data management.

I am a Lecturer in Japanese at the School of Languages and Cultures at UQ.

I work in the area of second language processing, which explores the cognitive mechanisms that underlie second language parsing and learning.

More specifically, I am interested in prediction-driven models in morphosyntactic processing. In language use, we anticipate what we will encounter next even before we receive the actual input. Existing work has shown the ability to predict what comes next is a key to efficiency and robustness in comprehension in native languages. My work examines to what extent such a process is operative in a nonnative language, and various factors that mediates that process.

To address these questions, I use behavioral research methods (e.g., reaction times, eye-tracking, comprehension and production tasks) and corpus-linguistic techniques.

I received my BA in English language and literature from Waseda University, Japan, MA and Ph.D in Second Language Acquisition from Carnegie Mellon University, USA. Prior to joining UQ, I worked at the University of Kansas, USA.

Dr Miura's research focus is the role of nutrition and dietary intake in prevention of chronic disease, especially skin cancer and cardiovascular disease. Dr Miura is currently leading projects to studying nutritional status and dietary intake among heart transplant recipients. Her research areas also extend to health of airline pilots in relation to radiation exposure.

My research focuses on sustainable tourism and ethical tourism. I have published on a wide range of themes in these areas, including wildlife tourism, environmentalism, tourism impacts, and air travel. I believe research should serve society and strive to tackle real world questions.

Professor Mobli is a structural biologist and a group leader at the University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN). He is well known internationally for his contributions to the basic theory of multidimensional nuclear magnetic resonance and its applications to resolving the molecular structure of peptides and proteins, as well as studying their physiochemical properties and function. Mehdi's contributions to the field has been recognised by being appointed an Executive Editor of the AMPERE society's journal "Magnetic Resonance", and to the advisory board of the international Biological Magnetic Resonance Data Bank (BMRB) as well as serving on the board of directors of the Australia and New Zealand Society for Magnetic Resonance (ANZMAG). He is a former ARC Future Fellow and recipient of the ASBMB MERCK medal, the Australia Peptide Society's Tregear Award, the ANZMAG Sir Paul Callaghan medal and the Lorne Proteins Young Investigator Award (now Robin Anders Award).

Prof. Mobli's research group focuses on characterising the structure and function of receptors involved in neuronal signalling, with a particular focus on developing new approaches for the discovery and characterisation of modulators of these receptors through innovations in bioinformatics, biochemistry and and biophysics. This work has led to publication of more than 100 research articles attracting over 6,000 citations.

I am an agricultural biotechnologist specialising in applications of nanotechnology to improve animal health. My PhD was a part of a multi-disciplinary research project facilitated by the Queensland Government Research Partnerships at QAAFI. This research, for the first time, established silica nanomaterials as carriers and self-adjuvants for vaccine development and delivery against Bovine Viral Diarrhoea Virus. As a Research Fellow at QAAFI, I am leading the research using RNA interference technology and material science to develop sustainable solutions for real-world problems like sheep blowfly and lice-infestation.

We are always seeking for motivated Honours and PhD applicants, please get in touch, if that sounds like you!

Miriam Moeller (PhD, MBA) is an Associate Professor in International Business at The University of Queensland Business School, Australia. Her research, published in top academic and practitioner journals, explores how effective procurement, inclusion, and mobilisation of talent support firm internationalisation. As a multi-generational expatriate with experience across 5 continents, her research examines the global work relocations of globally mobile talent and their accompaying families members. She has a special interest in marginalised and minority communities, including that of LGBTIQA+ expatriates, women expatriates, and neurodivergent expatriates. In recent years, Miriam’s focus has been on championing the development of neuroinclusive workplace practices, both in Australia and globally. She is a member of the UQ Disability Inclusion Advocacy Network and serves as Associate Editor at the International Journal of Management Reviews and editorial review board member at the Journal of Global Mobility.

Dr Gunn-Helen Moen was awarded her PhD on the "Genetic and environmental etiology of glucose metabolism and cardiometabolic traits during pregnancy and in later life" in 2019 from the Faculty of Medicine at the University of Oslo. After finishing her PhD, she was awarded a Mobility/Marie Sklodowska-Curie Fellowship from the Research Council of Norway and as part of that fellowship she spent two years as a visiting academic at the University of Queensland. She is currently an ARC DECRA fellow at IMB. Her research focus is on using Mendelian randomization to investigate the possible causal effects of maternal environmental exposures during pregnancy on offspring outcomes.

Peyman Moghadam is an Adjunct Associate Professor at the University of Queensland (UQ). He is a Principal Research Scientist at CSIRO Data61 as well as Professor (Adjunct) at the Queensland University of Technology (QUT). He leads the Embodied AI Research Cluster at CSIRO Data61, working at the intersection of Robotics and Machine learning. He is also the Spatiotemporal AI portfolio Leader at the CSIRO's Machine Learning and Artificial Intelligence (MLAI) Future Science Platform and oversees research and development of MLAI methods for scientific discovery in spatiotemporal data streams. In 2022, he served as a Visiting Professor at ETH Zürich. In 2019, he held a Visiting Scientist appointment at the University of Bonn. Peyman has led several large-scale multidisciplinary projects and won numerous awards, including CSIRO's Julius Career Award, National, and Queensland state iAward for Research and Development, CSIRO’s Collaboration Medal and the Lord Mayor’s Budding Entrepreneurs Award. His current research interests include self-supervised learning for robotics, embodied AI, 3D multi-modal perception (3D++), robotics, and computer vision.

Dr. Saeed Mohammadian is a postdoctoral research fellow in Transport Engineering. His primary research is on understanding freeway traffic flow dynamics and their safety implication with a special focus on the role of human factors. As part of his doctoral work, he has conducted critical meta-research on the state-of-the-art of macroscopic traffic flow modelling, from both theoretical and practical perspectives. The central part of his doctoral thesis develops unifiable mathematical models of traffic flow dynamics and rear-end crashes and presents new insight into the role of human factors on complex traffic phenomena and traffic safety.

His main work at UQ involves conducting research on driver interactions with connected and automated vehicles and studying the implications for both congestions and crashes. He is currently involved in several research projects related to freeway traffic flow modelling and control and safety assessment. His research outcomes can be explicitly utilized in traffic control research for moving towards faster and safer roads.

Dr Yousuf Mohammed completed his PhD in pharmaceutics and skin drug delivery under the guidance of Associate prof Heather Benson, Prof Michael Roberts and Associate prof Tarl Prow. He has been working within the field of skin delivery at the Therapeutics Research Centre, University of Queensland - School of Medicine since 2012. His current research includes managing a five-year (2018-2023) US FDA funded project titled Bioequivalence of Topical products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations as a Principle Investigator and managing the five-year project (2014-2019) Characterization of Critical Quality Attributes for Semisolid Topical Drug Products as a Co-investigator. These projects aims to improve current regulatory guidelines for topical and transdermal semisolid products. Over the last 6 years, his work has been focused on skin penetration and skin toxicology of drugs and xenobiotics including nanoparticulate materials.

In 2024, Dr Hisham Mohammed relocated to Brisbane to lead the Discipline of Orthodontics at the University of Queensland. He earned his dental degree from Future University, followed by a Master's in Orthodontics with Distinction from the University of Dundee. He completed his PhD at the University of Otago, where his research focused on studying the impact of malocclusion on smile aesthetics. He also holds the prestigious Specialty Membership in Orthodontics from the Royal Colleges of Surgeons of England and Glasgow.

Dr. Mohammed’s research interests include evidence-based orthodontics, smile analysis, artificial intelligence in orthodontics, and treatment outcomes involving miniscrew implants. His work has earned wide recognition, attracting extramural funds and prestigious accolades such as the Sir John Walsh Research Award.

Dr Devi Mohan, an Associate Professor in the School of Public Health is a physician with a specialization in Community Medicine and holds a Graduate Certificate in Higher Education.

Dr Mohan leads the public health teaching of the MD program and serves as the theme lead for Advocate for Health Improvement. She has extensive experience teaching in medical programs in both India and Malaysia, including integrated medical programs, and has mentored many medical graduates in medical research.

Dr Mohan's research primarily focuses on dementia epidemiology, prevention, and care in low and middle-income countries. Her work has been published in high impact public health and dementia journals. Currently, she leads various dementia research projects in Malaysia, Vietnam, and India. Working with various international research teams, Dr Mohan has secured research grants totalling over AUD 5 million from prestigious funding bodies such as NIHR UK, Australian Research Council, and MRC UK. She has mentored many PhD students and post-doctoral fellows, contributing to the development of the next generation of public health researchers.

As a member of the NIHR Global Health Group on Dementia Prevention and Enhanced Care (DePEC), Dr Mohan collaborates with international experts to develop approaches for reducing dementia risk and establishing sustainable care pathways. She has extensive international collaborations with partners in the UK, India, Malaysia, South-East Asia, focusing on projects related to aging and dementia. Dr Mohan is a member of Global Dementia Prevention Program, and the Southeast Asia Dementia Research Network.

Prior to her current role, Dr Mohan served as an Associate Professor in Global Public Health at the Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia. She has also worked with the Department of Health, Kerala, India, where she was actively involved in primary health care and delivery of health programs.

Dr Mollee practices as a consultant haematologist in clinical and laboratory haematology at the Princess Alexandra Hospital and is Associate Professor with the University of Queensland Medical School.

Having trained in Brisbane and Toronto, Dr Mollee has developed an international reputation studying amyloidosis and the plasma cell dyscrasias. He holds appointments with the Medical Scientific Advisory Group of Myeloma Australia, Australian Amyloidosis Network, National Blood Cancer Taskforce and is a member of the AACB Monoclonal Gammopathy Working Group and the International Kidney & Monoclonal Gammopathy Research Group. He is a past Chairman of the Australasian Leukaemia and Lymphoma Group (ALLG) and current Chair of the Australian Amyloidosis Network. He heads the Myeloma Service as well as the Queensland Amyloidosis Centre which runs one of the few clinics in Australia dedicated exclusively to the care of patients with amyloidosis.

Dr Tom Moloney is an ophthalmologist specialising in retinal and macular diseases, cataract surgery and vitreoretinal surgery.

Dr Moloney studied Medicine at the University of Queensland then completed specialist ophthalmology training in Queensland. He then undertook the Medical Retina and Uveitis Fellowship at the prestigious Moorfields Eye Hospital in London and subsequently returned to Brisbane to complete the Vitreoretinal Surgery Fellowship at the Royal Brisbane and Women’s Hospital. He was awarded the RANZCO Topham Scholarship to support his fellowship training in the United Kingdom.

He is a Fellow of the Royal Australian and New Zealand College of Ophthalmologists, a member of both the American Society of Retinal Specialists and the Australian and New Zealand Society of Retinal Specialists and a member of the American Society of Cataract and Refractive Surgeons.

Dr Moloney holds academic appointments at the University of Queensland and is involved with the teaching and training of medical students, optometrists and ophthalmology registrars.

Specialty Interests

Dr Moloney’s specialty interests include:

• Intravitreal injection and laser treatments for:
  • Age Related Macular Degeneration
  • Retinal Vein Occlusion
  • Diabetic Eye Disease
• Vitreoretinal surgery for:
  • Macular Hole
  • Epiretinal Membrane
  • Retinal Detachment
  • Secondary Intraocular Lens
• Cataract Surgery
• Pterygium Surgery

Dr Jayson Moloney is a colorectal surgeon and gastrointestinal endoscopist consulting and operating across Brisbane's north.

Jayson's clinical special interests include colorectal cancer, minimally-invasive (laparoscopic and robotic surgery) and complex pelvic surgery. He practices across the full breadth of colorectal surgery, including both benign and malignant disorders such as diverticular disease, inflammatory bowel disease, rectal prolapse and haemorrhoids.

In addition to private practice, Jayson also holds appointments as a colorectal surgeon at the Royal Brisbane and Women’s Hospital and is a Senior Lecturer with the University of Queensland.

Enquiries